SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about updates on acquisition

11 Jul 2025 Evaluate
Zim Laboratories has informed regarding the investment of AED 1,00,000 and 4,66,000 respectively, to be made in ZIM Scientific Office LLC Step-down Subsidiary of the Company (ZIM SO) by ZIM Laboratories FZE, Wholly Owned Subsidiary of the Company (ZIM FZE). In view of the above and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), the ZIM FZE has completed the process of investment of AED 4,00,000 in the shares capital of ZIM SO. Post investment, the shareholding of the ZIM FZE remains at 100% of the total share capital of ZIM SO. 

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

111.80 0.25 (0.22%)
16-Jun-2026 10:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.40
Dr. Reddys Lab 1284.10
Cipla 1387.50
Zydus Lifesciences 1086.00
Lupin 2268.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: